Drug Trial Radar · NCT06767540
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Jan 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
198
Planned (sponsor's estimate)
Start
Jan 23, 2025
Primary completion
Jul 10, 2027
Study completion Jul 10, 2027
Sponsor
- Lead sponsor
- AkesoIndustry
- Sponsor type
- Industry
- First posted
- Jan 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized double-blind, placebo-controlled, multicenter phase III clinical study evaluating the efficacy and safety of AK120 in the treatment of moderate-to-severe AD in adolescents.
Conditions
- Atopic Dermatitis
Interventions
PlaceboDrug
placebo subcutaneous injection Q2W until week 46.
placeboDrug
placebo subcutaneous injection Q3W until week 45.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of subjects who achieved Eczema Area and Severity Index (EASI)-75Time frame: at week 18 (day 127)
- Percentage of subjects with the Investigator's Global Assessment (IGA) score decrease of ≥ 2 pointsTime frame: at week 18 (day 127)
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Chongqing Traditional Chinese Medicine Hospital
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Dongguan People's Hospital
Dongguan, Guangdong, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, China
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Jiangmen Central Hospital
Jiangmen, Guangdong, China
The University of Hong Kong - Shenzhen Hospital
Shenzhen, Guangdong, China
The Third People's Hospital of Zhuhai
Zhuhai, Guangdong, China
Liuzhou Worker's Hospital
Liuzhou, Guangxi, China
Jinzhou Central Hospital
Jinzhou, Hubei, China
Tongji Hospital
Wuhan, Hubei, China
Hunan Children's Hospital
Changsha, Hunan, China
XiangYa Hospital CentralSouth University
Changsha, Hunan, China
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
Dermatology Hospital of Jiangxi Province
Nanchang, Jiangxi, China
Shandong Provincial Dermatology Hospital
Jinan, Shandong, China
Jining First People's Hospital
Jining, Shandong, China
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, China
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi’an, Shanxi, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
The First Hospital of Jiaxing
Jiaxing, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.